MedPath
HSA Approval

CO-MIDIS TABLETS 80MG/5MG

SIN16647P

CO-MIDIS TABLETS 80MG/5MG

CO-MIDIS TABLETS 80MG/5MG

November 24, 2022

NOVEM HEALTHCARE PTE LTD

NOVEM HEALTHCARE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM HEALTHCARE PTE LTD
Licence HolderNOVEM HEALTHCARE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09DB04

telmisartan and amlodipine

Manufacturer Information

NOVEM HEALTHCARE PTE LTD

Standard Chem. & Pharm. Co. Ltd.

Active Ingredients

Telmisartan

80 mg

Telmisartan

Amlodipine besylate eqv Amlodipine

5 mg

Amlodipine

Documents

Package Inserts

Co-Midis Tablet PI.pdf

Approved: November 24, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CO-MIDIS TABLETS 80MG/5MG - HSA Approval | MedPath